Home
/
CHAMPIONS ONCOLOGY, INC.
/
Financials
/
Quarterly
CHAMPIONS ONCOLOGY, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CHAMPIONS ONCOLOGY, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2019
Jul 31, 2018
$6.23M
Sep 14, 2018
Q1
2019
Jul 31, 2017
$5.03M
Sep 14, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 31, 2026
$16.56M
Mar 12, 2026
Q2
2026
Oct 31, 2025
$15.04M
Dec 15, 2025
Q1
2026
Jul 31, 2025
$14.00M
Sep 15, 2025
Q3
2026
Jan 31, 2025
$17.04M
Mar 12, 2026
Q2
2026
Oct 31, 2024
$13.49M
Dec 15, 2025
Q1
2026
Jul 31, 2024
$14.06M
Sep 15, 2025
Q3
2025
Jan 31, 2024
$12.02M
Mar 17, 2025
Q2
2025
Oct 31, 2023
$11.57M
Dec 16, 2024
Q1
2025
Jul 31, 2023
$12.56M
Sep 13, 2024
Q3
2024
Jan 31, 2023
$12.77M
Mar 15, 2024
Q2
2024
Oct 31, 2022
$14.28M
Dec 13, 2023
Q1
2024
Jul 31, 2022
$13.75M
Sep 13, 2023
Q3
2023
Jan 31, 2022
$13.19M
Mar 16, 2023
Q2
2023
Oct 31, 2021
$11.79M
Dec 13, 2022
Q1
2023
Jul 31, 2021
$11.25M
Sep 12, 2022
Q3
2022
Jan 31, 2021
$10.81M
Mar 15, 2022
Q2
2022
Oct 31, 2020
$10.12M
Dec 13, 2021
Q1
2022
Jul 31, 2020
$9.55M
Sep 13, 2021
Q3
2021
Jan 31, 2020
$9.01M
Mar 15, 2021
Q2
2021
Oct 31, 2019
$7.63M
Dec 14, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 31, 2026
($279.0K)
Mar 12, 2026
Q2
2026
Oct 31, 2025
$268.0K
Dec 15, 2025
Q1
2026
Jul 31, 2025
($436.0K)
Sep 15, 2025
Q3
2026
Jan 31, 2025
$4.50M
Mar 12, 2026
Q2
2026
Oct 31, 2024
$728.0K
Dec 15, 2025
Q3
2025
Oct 31, 2024
$728.0K
Mar 17, 2025
Q3
2025
Jul 31, 2024
$1.31M
Mar 17, 2025
Q2
2025
Jul 31, 2024
$1.31M
Dec 16, 2024
Q1
2026
Jul 31, 2024
$1.31M
Sep 15, 2025
Q1
2025
Apr 30, 2024
($7.30M)
Sep 13, 2024
Q3
2025
Jan 31, 2024
($2.53M)
Mar 17, 2025
Q2
2025
Oct 31, 2023
($2.07M)
Dec 16, 2024
Q3
2025
Oct 31, 2023
($2.07M)
Mar 17, 2025
Q2
2025
Jul 31, 2023
($2.57M)
Dec 16, 2024
Q3
2025
Jul 31, 2023
($2.57M)
Mar 17, 2025
Q1
2025
Jul 31, 2023
($2.57M)
Sep 13, 2024
Q3
2024
Jan 31, 2023
($2.44M)
Mar 15, 2024
Q2
2024
Oct 31, 2022
($16.0K)
Dec 13, 2023
Q3
2024
Oct 31, 2022
($16.0K)
Mar 15, 2024
Q3
2024
Jul 31, 2022
($319.0K)
Mar 15, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 31, 2026
($276.0K)
Mar 12, 2026
Q2
2026
Oct 31, 2025
$185.0K
Dec 15, 2025
Q1
2026
Jul 31, 2025
($527.0K)
Sep 15, 2025
Q3
2026
Jan 31, 2025
$4.50M
Mar 12, 2026
Q2
2026
Oct 31, 2024
$732.0K
Dec 15, 2025
Q1
2026
Jul 31, 2024
$1.33M
Sep 15, 2025
Q3
2025
Jan 31, 2024
($2.58M)
Mar 17, 2025
Q2
2025
Oct 31, 2023
($1.96M)
Dec 16, 2024
Q1
2025
Jul 31, 2023
($2.55M)
Sep 13, 2024
Q3
2024
Jan 31, 2023
($2.46M)
Mar 15, 2024
Q2
2024
Oct 31, 2022
$7.0K
Dec 13, 2023
Q1
2024
Jul 31, 2022
($284.0K)
Sep 13, 2023
Q3
2023
Jan 31, 2022
$830.0K
Mar 16, 2023
Q2
2023
Oct 31, 2021
$263.0K
Dec 13, 2022
Q1
2023
Jul 31, 2021
($175.0K)
Sep 12, 2022
Q3
2022
Jan 31, 2021
$982.0K
Mar 15, 2022
Q2
2022
Oct 31, 2020
$7.0K
Dec 13, 2021
Q1
2022
Jul 31, 2020
$24.0K
Sep 13, 2021
Q3
2021
Jan 31, 2020
$433.0K
Mar 15, 2021
Q2
2021
Oct 31, 2019
$291.0K
Dec 14, 2020